# TeloPoint

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/telopoint

- Industry: Healthcare
- Headquarters: New York, US
- Website: www.telopoint.com
- Total disclosed funding: $0.1M
- Latest round: Seed (Nov 20, 2020)
- Investors on record: 1

## About

TeloPoint Inc. specializes in providing comprehensive preventive care solutions that enhance early detection and intervention in healthcare, focusing on underserved populations to improve access to diagnostic services.TeloPoint Inc. is focused on enhancing healthcare accessibility through innovative preventive care solutions. Founded by Erik Wildt and Young Lee, the company is headquartered in New York, US. In November 2020, TeloPoint raised USD 0.15 million in Seed funding from Jumpstart Health Investors, marking their latest round of financing which is also the total amount raised.TeloPoint’s primary offerings consist of a comprehensive preventive care solution designed to enhance early detection and intervention in healthcare. This solution effectively integrates various healthcare point services to create a seamless patient journey, aimed at addressing barriers to diagnostic care access. By focusing on underserved populations, TeloPoint provides in-home and group visit options that cater to mobility-constrained members, allowing them to receive necessary screenings and treatments for conditions such as diabetes and chronic kidney disease (CKD) in a timely manner. Their services are primarily targeted at health plans, healthcare providers, and health systems across the United States, facilitating improved health outcomes by driving higher compliance rates for chronic disease management (CDM) cohorts and expanding access to essential diagnostic services.TeloPoint generates revenue through strategic partnerships and collaborations with health plans and healthcare providers, leveraging a model that emphasizes value-based care. Their services are structured to optimize reimbursement opportunities from programs like Medicare through risk adjustment, which rewards the identification and management of chronic diseases. The company’s offerings may include a subscription model for ongoing access to their suite of capabilities, which encompasses SMS communications, telephonic outreach, and online business intelligence dashboards. The financial transactions typically occur on a B2B basis, enabling health plans to integrate TeloPoint’s preventive care solutions into their existing frameworks and enhance their service offerings to members. This transactional structure supports consistent revenue streams while promoting better health outcomes for the populations served.Following the recent Seed funding round in November 2020, TeloPoint is poised to expand its product offerings and market reach. The funding will be utilized to develop new healthcare solutions aimed at increasing early detection capabilities and to enhance existing services. Additionally, TeloPoint aims to expand its operations beyond its current markets, targeting new geographic regions across the United States to improve healthcare access. This strategic growth is expected to facilitate better health outcomes for underserved populations, aligning with TeloPoint's mission of addressing disparities in healthcare access.

## Funding rounds

- Seed, Nov 20, 2020, $0.1M — Jumpstart Health Investors

## Investors

- Jumpstart Health Investors (https://capitalatlas.ai/funds/jumpstart-health-investors) — Seed